Search results for "PLOT"

showing 10 items of 830 documents

Dalitz plot analyses ofB0→D−D0K+andB+→D¯0D0K+decays

2015

We present Dalitz plot analyses for the decays of B mesons to D^−D^0K^+ and D^0D^0K^+. We report the observation of the D^∗_(s1)(2700)^+ resonance in these two channels and obtain measurements of the mass M(D^∗_(s1)(2700)+)=2699^(+14)_(−7)  MeV/c^2 and of the width Γ(D^∗_(s1)(2700)+)=127^(+24)_(−19)  MeV, including statistical and systematic uncertainties. In addition, we observe an enhancement in the D^0K^+ invariant mass around 2350–2500  MeV/c^2 in both decays B^0→D^−D^0K^+ and B^+→D^0D^0K^+, which we are not able to interpret. The results are based on 429  fb^(−1) of data containing 471×10^6BB pairs collected at the Υ(4S) resonance with the BABAR detector at the SLAC National Accelerato…

Nuclear physicsPhysicsNuclear and High Energy PhysicsMeson010308 nuclear & particles physics0103 physical sciencesResonanceDalitz plotInvariant massB meson010306 general physics01 natural sciencesPhysical Review D
researchProduct

Study ofB±,0→J/ψK+K−K±,0and search forB0→J/ψϕatBaBar

2015

We study the rare B meson decays B{+-,0} --> J/\psi\ K^+ K^- K{+-,0}, B{+-,0} --> J/\psi\ \phi\ K{+-,0}, and search for B0 --> J/\psi\ \phi, using 469 million BBbar events collected at the Upsilon(4S) resonance with the BABAR detector at the PEP-II e+e- asymmetric-energy collider. We present new measurements of branching fractions and a study of the J/\psi\phi mass distribution in search of new charmonium-like states. In addition, we search for the decay B0 --> J/\psi\ \phi, and find no evidence of a signal.

Nuclear physicsPhysicsNuclear and High Energy PhysicsParticle physics010308 nuclear & particles physicsElectron–positron annihilation0103 physical sciencesResonanceDalitz plotHigh Energy Physics::ExperimentB meson010306 general physics01 natural sciencesPhysical Review D
researchProduct

High statistics study of ƒ0(1500)s decay into ηη

1995

Abstract A partial wave analysis of the reaction p p →π o ηη has been performed, using a high quality, high statistics data set of 198,000 events. In addition to the ƒ 0 (1370), a second scalar resonance decaying into ηη, the ƒ 0 (1500), with mass m = (1505 ± 15) MeV and width Γ = (120 ± 30) MeV has to be introduced to describe the data.

Nuclear physicsPhysicsNuclear and High Energy PhysicsParticle physicsQuality (physics)Partial wave analysisScalar (mathematics)StatisticsDalitz plotResonancePhysics Letters B
researchProduct

Hidden and open $$\bar ss$$ production in $$\bar pp$$ annihilation at restannihilation at rest

1994

New branching ratios for\(\bar pp\) annihilation at rest into final states with a\(K\bar K\) pair or φ-meson are being measured with the Crystal Barrel detector at LEAR. The yield of φγ, relative to ωγ, appears to violate the OZI rule as strongly as φπ relative to ωπ.

Nuclear physicsPhysicsParticle physicsAnnihilationOZI ruleHigh Energy Physics::PhenomenologyDalitz plotHigh Energy Physics::ExperimentIl Nuovo Cimento A Series 11
researchProduct

$$N\bar N$$ annihilation at rest into five pions

1993

\(N\bar N\) annihilation at rest into five pions was studied in the ASTERIX spectrometer by stopping antiprotrons from LEAR in a H2 or D2 gas target. In\(\bar pp\) annihilations in H2 leading to the π+π−π+π−π0 final state, the invariant mass spectra of two, three, and four pions show no evidence for any new narrow states. In\(\bar pn \to \pi ^ + \pi ^ - \pi ^ + \pi ^ - \pi ^ - \) the difference of the four pion mass spectra recoiling against a π− and those recoiling against a π+ shows a resonance-like structure (“ζ (1480)”), confirming a previous analysis with a smaller event sample. The ζ (1480) mass is shown to depend strongly on the momentum of the spectator proton. In H2, we searched fo…

Nuclear physicsPhysicsParticle physicsPionAnnihilationPhysics and Astronomy (miscellaneous)MesonProtonBranching fractionMass spectrumDalitz plotEngineering (miscellaneous)OmegaZeitschrift f�r Physik C Particles and Fields
researchProduct

Evidence for two isospin zeroJ PC=2−+ mesons at 1645 and 1875 MeV

1996

Data on\(\bar pp \to \eta \pi ^0 \pi ^0 \pi ^0 \) taken at beam momenta of 1.2 and 1.94 GeV/c reveal evidence for twoI=0JPC=2−+ resonances inηππ. The first, at 1645±14(stat.)±15(syst.) MeV with width 180−21+40±25 MeV, decays toα2(1320)π withL=0. It may be interpreted as the\(q\bar q^1 \)D2 partner ofπ2(1670). A strong signal is also observed just above threshold inf2(1270)η withL=0. It is 11–22 times stronger than is expected for the high mass tail of the 1645 MeV resonance. It can be fitted as a second 2−+ resonance at 1875±20±35 MeV with width 200±25±45 MeV. A third resonance havingJPC=2++ is observed at 2135±20±45 MeV withΛ=250±25±45 MeV, decaying to botha2(1320)π andf2(1270)η withL=1. T…

Nuclear physicsPhysicsPhysics and Astronomy (miscellaneous)MesonIsospinZero (complex analysis)High massDalitz plotResonanceAtomic physicsRest frameBar (unit)Zeitschrift für Physik C: Particles and Fields
researchProduct

High-statistics analysis of $$\bar pp \to \pi ^0 \pi ^0 \pi ^0 $$ at restat rest

1994

Antiproton-proton annihilation at rest into 3π0 is analysed based on a data sample of about 500 000 high-quality 3π0 events. In this high-statistics Dalitz plot two structures in the region of π0π0 invariant masses of about 1500 MeV show up, a small band and a blob at higher masses. In a first attempt to describe the data two different models are used to parametrize the dynamical amplitudes leading to the same conclusion: the data require a 0+ + and also a 2+ + resonance in the 1500 MeV region.

Nuclear physicsRest (physics)PhysicsParticle physicsAnnihilationAmplitudePiDalitz plotInvariant (mathematics)Nuclear ExperimentResonance (particle physics)Bar (unit)Il Nuovo Cimento A Series 11
researchProduct

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

2010

Abstract The known breast cancer susceptibility polymorphisms in FGFR2, TNRC9/TOX3, MAP3K1, LSP1, and 2q35 confer increased risks of breast cancer for BRCA1 or BRCA2 mutation carriers. We evaluated the associations of 3 additional single nucleotide polymorphisms (SNPs), rs4973768 in SLC4A7/NEK10, rs6504950 in STXBP4/COX11, and rs10941679 at 5p12, and reanalyzed the previous associations using additional carriers in a sample of 12,525 BRCA1 and 7,409 BRCA2 carriers. Additionally, we investigated potential interactions between SNPs and assessed the implications for risk prediction. The minor alleles of rs4973768 and rs10941679 were associated with increased breast cancer risk for BRCA2 carrie…

OncologyCancer Researchendocrine system diseasesVesicular Transport ProteinsGene mutation0302 clinical medicineRisk FactorsGenotypeskin and connective tissue diseasesAged 80 and over0303 health sciencesBRCA1 ProteinHigh Mobility Group ProteinsMiddle Aged3. Good healthOncology030220 oncology & carcinogenesisFemaleBreast diseaseReceptors ProgesteroneAdultHeterozygotemedicine.medical_specialtyGenotypeBreast NeoplasmsSingle-nucleotide polymorphismBiologyPolymorphism Single NucleotideRisk AssessmentArticle03 medical and health sciencesBreast cancerSDG 3 - Good Health and Well-beingInternal medicinemedicineHumansGenetic Predisposition to DiseaseAllelesAged030304 developmental biologyBRCA2 ProteinHereditary cancer and cancer-related syndromes [ONCOL 1]Sodium-Bicarbonate SymportersHaplotypeCancergenome-wide association estrogen-receptor loci variantsmedicine.diseaseSurvival AnalysisTOX3MutationTrans-ActivatorsCancer researchApoptosis Regulatory Proteins
researchProduct

Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies

2007

Therapy-related myelodysplasia and acute myeloid leukemia (t-MDS/AML) is a malignancy occurring after exposure to chemotherapy and/or radiotherapy. Polymorphisms involved in chemotherapy/radiotherapy response genes could be related to an increased risk of developing this neoplasia. We have studied 11 polymorphisms in genes of drug detoxification pathways (NQO1, glutathione S-transferase pi) and DNA repair xeroderma pigmentosum, complementation group (3) (XPC(3), X-ray repair cross complementing protein (1)), Nijmegen breakage syndrome (1), excision repair cross-complementing rodent repair deficiency, complementation group (5) and X-ray repair cross complementing protein (3) and in the methy…

OncologyCancer Researchmedicine.medical_specialtyXeroderma pigmentosumAntineoplastic AgentsBreast NeoplasmsSingle-nucleotide polymorphismPolymorphism Single NucleotideBreast cancerRisk Factorshemic and lymphatic diseasesInternal medicinemedicineHumansMethylenetetrahydrofolate Reductase (NADPH2)Leukemiabiologybusiness.industryHaplotypeMyeloid leukemiaNeoplasms Second PrimaryHematologyMiddle Agedmedicine.diseaseHaplotypesOncologyCase-Control StudiesHematologic NeoplasmsMethylenetetrahydrofolate reductaseImmunologybiology.proteinbusinessNijmegen breakage syndromeNucleotide excision repairLeukemia
researchProduct

Donors with KIR-Bx Haplotypes Improve Outcome of Unrelated Hematopoietic Stem Cell Transplantation for Recipients with a Myeloid Malignant Disease an…

2015

relapse, or transplant related mortality (TRM) (p1⁄40.2, p1⁄40.1, p1⁄40.08, respectively). To investigate why higher CPSS scores were associated with higher mortality, we performed analysis restricted to patients with relapse following HCT. Those with intermediate-2/high riskhadnearly two-fold increase in riskof death after relapse compared to thosewith low/intermediate1 CPSS scores. Corresponding rates for low/intermediate-1 risk groups,OSat1year, 3years, and5yearswere61%,48%, and44% respectivelyand for intermediate-2/high riskgroupswere 38%, 32%, and19%respectively.OSofpatientswho receivedpre-HCT treatment with hypomethylating agents, chemotherapy, or both was not different compared to th…

OncologyChemotherapymedicine.medical_specialtyTransplantationMyeloidbusiness.industrymedicine.medical_treatmentHaplotypeHematopoietic stem cell transplantationTransplant-Related MortalityHematologyLigand (biochemistry)Phenotype3. Good healthmedicine.anatomical_structureInternal medicinemedicineBone marrowbusinessBiology of Blood and Marrow Transplantation
researchProduct